全文获取类型
收费全文 | 513322篇 |
免费 | 33972篇 |
国内免费 | 613篇 |
专业分类
耳鼻咽喉 | 6893篇 |
儿科学 | 16838篇 |
妇产科学 | 13521篇 |
基础医学 | 85009篇 |
口腔科学 | 14472篇 |
临床医学 | 44337篇 |
内科学 | 93604篇 |
皮肤病学 | 12154篇 |
神经病学 | 36180篇 |
特种医学 | 18453篇 |
外国民族医学 | 63篇 |
外科学 | 77035篇 |
综合类 | 8471篇 |
一般理论 | 118篇 |
预防医学 | 38966篇 |
眼科学 | 12134篇 |
药学 | 40537篇 |
中国医学 | 1006篇 |
肿瘤学 | 28116篇 |
出版年
2018年 | 4930篇 |
2015年 | 4508篇 |
2014年 | 6059篇 |
2013年 | 9544篇 |
2012年 | 12866篇 |
2011年 | 14268篇 |
2010年 | 8299篇 |
2009年 | 7770篇 |
2008年 | 13692篇 |
2007年 | 14695篇 |
2006年 | 14937篇 |
2005年 | 14353篇 |
2004年 | 14045篇 |
2003年 | 13387篇 |
2002年 | 13267篇 |
2001年 | 24067篇 |
2000年 | 25078篇 |
1999年 | 20555篇 |
1998年 | 5426篇 |
1997年 | 4705篇 |
1996年 | 5041篇 |
1995年 | 4625篇 |
1994年 | 4318篇 |
1993年 | 4135篇 |
1992年 | 15725篇 |
1991年 | 16309篇 |
1990年 | 16422篇 |
1989年 | 15796篇 |
1988年 | 14575篇 |
1987年 | 14419篇 |
1986年 | 13597篇 |
1985年 | 12975篇 |
1984年 | 9627篇 |
1983年 | 8247篇 |
1982年 | 4559篇 |
1981年 | 4229篇 |
1979年 | 9418篇 |
1978年 | 6855篇 |
1977年 | 5772篇 |
1976年 | 5602篇 |
1975年 | 6396篇 |
1974年 | 7634篇 |
1973年 | 7130篇 |
1972年 | 6960篇 |
1971年 | 6685篇 |
1970年 | 6172篇 |
1969年 | 5888篇 |
1968年 | 5559篇 |
1967年 | 5012篇 |
1966年 | 4450篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
131.
132.
133.
134.
AIMS: To examine the effects of agents that alter potassium adenosine triphosphate (KATP) channel activity in beta-cells on cognitive function and counterregulatory hormone responses during acute hypoglycaemia, given the physiological similarities between the pancreatic beta-cell and the hypothalamic glucose-sensitive neurones (GSN) and the widespread distribution of sulphonylurea receptors in neuronal cells throughout the brain. METHODS: Ten healthy males were studied on four occasions and in random order underwent three stepped hypoglycaemic (plasma glucose aims: 3.4, 2.8, 2.4 mmol/l) and one euglycaemic (plasma glucose aim: 5 mmol/l) insulin clamps. Prior to each hypoglycaemic study, volunteers received either 10 mg glibenclamide, or 5 mg/kg diazoxide or placebo orally. Cognitive function, symptom scores and counterregulatory hormone responses were measured at each glycaemic level. RESULTS: There was no statistically significant effect of either drug on the symptoms generated or the counterregulatory hormonal response during hypoglycaemia. However, cognitive function was better preserved during hypoglycaemia in the glibenclamide-treated arm, particularly four-choice reaction time which deteriorated at a plasma glucose 2.5 mmol/l compared with 3.0 mmol/l with diazoxide (P = 0.015) and 2.9 mmol/l with placebo (P = 0.114). CONCLUSIONS: Single doses of pharmacological agents which alter membrane KATP channel activity do not affect the counterregulatory response to hypoglycaemia but may modify cognitive function during cerebral glucopenia. The unexpected effects of glibenclamide on cortical function suggest a novel action of sulphonylureas that warrants further investigation. 相似文献
135.
Analyzing and shaping human attentional networks. 总被引:12,自引:0,他引:12
In this paper we outline a conception of attentional networks arising from imaging studies as connections between activated brain areas carrying out localized mental operations. We consider both the areas of functional activation (nodes) and the structural (DTI) and functional connections (DCM) between them in real time (EEG, frequency analysis) as important tools in analyzing the network. The efficiency of network function involves the time course of activation of nodes and their connectivity to other areas of the network. We outline landmarks in the development of brain networks underlying executive attention from infancy and childhood. We use individual differences in network efficiency to examine genetic alleles that are related to performance. We consider how animal studies might be used to determine the genes that influence network development. Finally we indicate how training may aid in enhancing attentional networks. Our goal is to show the wide range of methods that can be used to suggest and analyze models of network function in the study of attention. 相似文献
136.
P F Plouin D L Clement H Boccalon J Dormandy I Durand-Zaleski G Fowkes L Norgren T Brown 《International angiology》2003,22(4):333-339
Atherosclerotic renal artery stenosis (ARAS) may cause hypertension, progressive renal failure, and recurrent pulmonary edema. It typically occurs in high risk patients with coexistent vascular disease elsewhere. Most patients with ARAS are likely to die from coronary heart disease or stroke before end-stage renal failure occurs. Recent controlled trials have shown that most patients undergoing angioplasty to treat renovascular hypertension still need antihypertensive agents 6 or 12 months after the procedure. Nevertheless, the number of antihypertensive agents required to control blood pressure adequately is lower following angioplasty than for medication alone. Trials assessing the value of revascularization for preserving renal function or preventing clinical events are only in the early recruitment phase. Revascularization should be undertaken in patients with ARAS and resistant hypertension or heart failure, and probably in those with rapidly deteriorating renal function or with an increase in plasma creatinine levels during angiotensin-converting enzyme inhibition. With or without revascularization, medical therapy using antihypertensive, hypolipidemic and antiplatelet agents is necessary in almost all cases. 相似文献
137.
S. V. Terent’eva E. N. Komarova T. N. Sapozhnikova A. T. Teplyakov E. A. Ivanovskaya T. I. Andreeva 《Pharmaceutical Chemistry Journal》2006,40(12):694-696
A rapid procedure for determining angiotensin II in the blood by inverse voltammetry using a TA-2 device (Tekhnoanalit Company,
Tomsk) with a graphite electrode has been developed. The results of analyses using the proposed technique agree with the clinical
data. The rapid analytical procedure favors optimization of cardiotropic drug therapy.
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 40, No. 12, pp. 54–56, December, 2006. 相似文献
138.
139.
140.
I. DIMOVA B. ZAHARIEVA S. RAITCHEVA† R. DIMITROV‡ N. DOGANOV‡ & D. TONCHEVA 《International journal of gynecological cancer》2006,16(1):145-151
The objective of this study was to assess the implication of copy number changes of epidermal growth factor receptor (EGFR) and erbB2 genes in the etiology and progression of ovarian tumors. In our study, we used the highly reliable method of fluorescent in situ hybridization, applied on tissue microarray, containing 1006 ovarian tumors from different malignancy, histologic type and grade, and tumor stage, in order to analyze the correlations between gene copy number changes and tumor phenotype. We established copy number changes of erbB2 in 15.30% of malignant ovarian tumors-8.16% amplifications and 7.14% gains. The frequency of EGFR copy number changes was 10.67%-3.65% amplifications and 7.02% gains. EGFR gains occurred with approximately the same frequency in malignant (7.02%), low malignant potential (8.33%), and benign (7.19%) ovarian tumors. ErbB2 amplification was associated with clear cell type of ovarian cancer (P < 0.04). No amplification of EGFR and erbB2 genes was established in tumors with low malignant potency and in benign tumors. Regarding cancer phenotype, there was no statistically significant association between erbB2 copy number changes and histologic grade as well as tumor stage of ovarian cancer. EGFR gains are early events in ovarian tumorigenesis. Our results showed similar frequencies of EGFR gains in different grade tumors, while EGFR amplification increased from grades 1 to 2 to 3. 相似文献